Cargando...
PATH-39. A NEW MOLECULAR PROGNOSTIC MARKER FOR MALIGNANT GLIOMA
Glioma is the most popular primary CNS tumor and especially, Glioblastoma multiforme (GBM), WHO Grade IV glioma, is the worst prognostic tumor in all systemic cancers. Despite maximum resection followed by chemoradiotherapy, the overall median survival is only about 15 months. To date, molecular res...
Gardado en:
| Publicado en: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692468/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.729 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|